Literature DB >> 1612750

Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae.

B D Carlsen1, M Kawana, C Kawana, A Tomasz, G S Giebink.   

Abstract

The pathogenesis of middle ear inflammation caused by Streptococcus pneumoniae was explored in the chinchilla model with different pneumococcal cell wall (CW) preparations, including isolated native CW, M1 muramidase CW (M1-CW) digest, amidase CW digest, and M1 peptidoglycan (M1-PG) digest. Inflammatory cell and lysozyme concentrations in middle ear fluid (MEF) were measured between 6 and 72 h after the middle ears were inoculated with one of the preparations or sterile saline. Middle ear histopathology was measured quantitatively at 72 h. Native CW, M1-CW digest, and amidase-CW digest caused significantly more inflammatory cell influx and lysozyme accumulation in MEF than saline did. M1-PG digest also caused more inflammatory cell influx and lysozyme accumulation in MEF than saline did but caused less inflammation than native CW or either CW digest. Epithelial metaplasia was significantly greater in ears inoculated with native CW than in ears inoculated with the CW or PG digest or with saline. Pneumococcal CW is, therefore, the principal factor that initiates middle ear inflammation in acute pneumococcal otitis media, and CW teichoication seems to be important in initiating this response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612750      PMCID: PMC257244          DOI: 10.1128/iai.60.7.2850-2854.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media.

Authors:  M L Ripley-Petzoldt; G S Giebink; S K Juhn; D Aeppli; A Tomasz; E Tuomanen
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.

Authors:  E Tuomanen; B Hengstler; R Rich; M A Bray; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

3.  Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.

Authors:  M Kawana; C Kawana; G S Giebink
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.

Authors:  E Tuomanen; A Tomasz; B Hengstler; O Zak
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

5.  Chronic middle ear effusions. Immunochemical and bacteriological investigations.

Authors:  Y S Liu; D J Lim; R W Lang; H G Birck
Journal:  Arch Otolaryngol       Date:  1975-05

6.  Generation of purpura-producing principle from pneumococcal cell walls.

Authors:  C Chetty; A Kreger
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

7.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  Cross-reactions between pneumococci and other streptococci due to C polysaccharide and F antigen.

Authors:  U B Sørensen; J Henrichsen
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

9.  Otitis media with effusion following inoculation of Haemophilus influenzae type b endotoxin.

Authors:  N Nonomura; Y Nakano; Y Satoh; O Fujioka; H Niijima; M Fujita
Journal:  Arch Otorhinolaryngol       Date:  1986

10.  C-reactive protein is protective against Streptococcus pneumoniae infection in mice.

Authors:  C Mold; S Nakayama; T J Holzer; H Gewurz; T W Du Clos
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  8 in total

1.  Allelic variation in Streptococcus pneumoniae autolysin (N-acetyl muramoyl-L-alanine amidase).

Authors:  S H Gillespie; T D McHugh; H Ayres; A Dickens; A Efstratiou; G C Whiting
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 2.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Mary E Marquart
Journal:  J Bacteriol Parasitol       Date:  2011

Review 4.  Acute otitis media with spontaneous tympanic membrane perforation.

Authors:  N Principi; P Marchisio; C Rosazza; C S Sciarrabba; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

Review 5.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

6.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

7.  Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation.

Authors:  K Sato; M K Quartey; C L Liebeler; G S Giebink
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

8.  In vivo capsular switch in Streptococcus pneumoniae--analysis by whole genome sequencing.

Authors:  Fen Z Hu; Rory Eutsey; Azad Ahmed; Nelson Frazao; Evan Powell; N Luisa Hiller; Todd Hillman; Farrel J Buchinsky; Robert Boissy; Benjamin Janto; Jennifer Kress-Bennett; Mark Longwell; Suzanne Ezzo; J Christopher Post; Mirjana Nesin; Alexander Tomasz; Garth D Ehrlich
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.